• Je něco špatně v tomto záznamu ?

Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site

M. Vojsovič, L. Kratochvilová, N. Valková, L. Šislerová, Z. El Rashed, P. Menichini, A. Inga, P. Monti, V. Brázda

. 2024 ; 216 (-) : 14-23. [pub] 20231013

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007821

The effect of mutations in the P53 family of transcription factors on their biological functions, including partial or complete loss of transcriptional activity, has been confirmed several times. At present, P53 family proteins showing partial loss of activity appear to be promising potential candidates for the development of novel therapeutic strategies which could restore their transcriptional activity. In this context, it is important to employ tools to precisely monitor their activity; in relation to this, non-canonical DNA secondary structures in promoters including G-quadruplexes (G4s) were shown to influence the activity of transcription factors. Here, we used a defined yeast assay to evaluate the impact of differently modeled G4 forming sequences on a panel of partial function P53 family mutant proteins. Specifically, a 22-mer G4 prone sequence (derived from the KSHV virus) and five derivatives that progressively mutate characteristic guanine stretches were placed upstream of a minimal promoter, adjacent to a P53 response element in otherwise isogenic yeast luciferase reporter strains. The transactivation ability of cancer-associated P53 (TA-P53α: A161T, R213L, N235S, V272L, R282W, R283C, R337C, R337H, and G360V) or Ectodermal Dyplasia syndromes-related P63 mutant proteins (ΔN-P63α: G134D, G134V and inR155) were tested. Our results show that the presence of G4 forming sequences can increase the transactivation ability of partial function P53 family proteins. These observations are pointing to the importance of DNA structural characteristics for accurate classification of P53 family proteins functionality in the context of the wide variety of TP53 and TP63 germline and somatic mutations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007821
003      
CZ-PrNML
005      
20240423160310.0
007      
ta
008      
240412e20231013fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.biochi.2023.09.026 $2 doi
035    __
$a (PubMed)37838351
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Vojsovič, Matúš $u Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61200, Brno, Czech Republic; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkyňova 118, 61200, Brno, Czech Republic. Electronic address: matusvojovic98@gmail.com
245    10
$a Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site / $c M. Vojsovič, L. Kratochvilová, N. Valková, L. Šislerová, Z. El Rashed, P. Menichini, A. Inga, P. Monti, V. Brázda
520    9_
$a The effect of mutations in the P53 family of transcription factors on their biological functions, including partial or complete loss of transcriptional activity, has been confirmed several times. At present, P53 family proteins showing partial loss of activity appear to be promising potential candidates for the development of novel therapeutic strategies which could restore their transcriptional activity. In this context, it is important to employ tools to precisely monitor their activity; in relation to this, non-canonical DNA secondary structures in promoters including G-quadruplexes (G4s) were shown to influence the activity of transcription factors. Here, we used a defined yeast assay to evaluate the impact of differently modeled G4 forming sequences on a panel of partial function P53 family mutant proteins. Specifically, a 22-mer G4 prone sequence (derived from the KSHV virus) and five derivatives that progressively mutate characteristic guanine stretches were placed upstream of a minimal promoter, adjacent to a P53 response element in otherwise isogenic yeast luciferase reporter strains. The transactivation ability of cancer-associated P53 (TA-P53α: A161T, R213L, N235S, V272L, R282W, R283C, R337C, R337H, and G360V) or Ectodermal Dyplasia syndromes-related P63 mutant proteins (ΔN-P63α: G134D, G134V and inR155) were tested. Our results show that the presence of G4 forming sequences can increase the transactivation ability of partial function P53 family proteins. These observations are pointing to the importance of DNA structural characteristics for accurate classification of P53 family proteins functionality in the context of the wide variety of TP53 and TP63 germline and somatic mutations.
650    12
$a nádorový supresorový protein p53 $x metabolismus $7 D016159
650    _2
$a aktivace transkripce $7 D015533
650    _2
$a Saccharomyces cerevisiae $x genetika $x metabolismus $7 D012441
650    12
$a G-kvadruplexy $7 D054856
650    _2
$a transkripční faktory $x metabolismus $7 D014157
650    _2
$a DNA $x chemie $7 D004247
650    _2
$a mutantní proteiny $x genetika $7 D050505
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kratochvilová, Libuše $u Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61200, Brno, Czech Republic; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkyňova 118, 61200, Brno, Czech Republic. Electronic address: kratochvilova@ibp.cz
700    1_
$a Valková, Natália $u Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61200, Brno, Czech Republic. Electronic address: nataliabohalova@gmail.com
700    1_
$a Šislerová, Lucie $u Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61200, Brno, Czech Republic; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkyňova 118, 61200, Brno, Czech Republic. Electronic address: l.sislerova@ibp.cz
700    1_
$a El Rashed, Zeinab $u Gene Expression Regulation, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy. Electronic address: zeinab.elrashed@hsanmartino.it
700    1_
$a Menichini, Paola $u Mutagenesis and Cancer Prevention, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy. Electronic address: paola.menichini@hsanmartino.it
700    1_
$a Inga, Alberto $u Laboratory of Transcriptional Networks, Department of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123, Trento, Italy. Electronic address: alberto.inga@unitn.it
700    1_
$a Monti, Paola $u Mutagenesis and Cancer Prevention, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy. Electronic address: paola.monti@hsanmartino.it
700    1_
$a Brázda, Václav $u Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61200, Brno, Czech Republic; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkyňova 118, 61200, Brno, Czech Republic. Electronic address: vaclav@ibp.cz
773    0_
$w MED00009325 $t Biochimie $x 1638-6183 $g Roč. 216 (20231013), s. 14-23
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37838351 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423160306 $b ABA008
999    __
$a ok $b bmc $g 2081676 $s 1217588
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 216 $c - $d 14-23 $e 20231013 $i 1638-6183 $m Biochimie $n Biochimie $x MED00009325
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...